Frequent pathway mutations of splicing machinery in myelodysplasia
about
The spectrum of SWI/SNF mutations, ubiquitous in human cancersCancer genome landscapesDBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongationGermline ETV6 mutations in familial thrombocytopenia and hematologic malignancyACTN1 mutations cause congenital macrothrombocytopeniaNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesClinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsSafety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndromeModulating splicing with small molecular inhibitors of the spliceosomeRecent advances in understanding myelofibrosis and essential thrombocythemiaSpliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesisCytogenetic and molecular abnormalities in chronic myelomonocytic leukemiaAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerMolecular landscape of acute myeloid leukemia in younger adults and its clinical relevanceBiology of Heme in Mammalian Erythroid Cells and Related DisordersIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Prp40 and early events in splice site definitionDefects in spliceosomal machinery: a new pathway of leukaemogenesisThe significance of spliceosome mutations in chronic lymphocytic leukemiaFrom human genome to cancer genome: the first decadeEngineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?Applications of next-generation sequencing to blood and marrow transplantationBreaking bad: R-loops and genome integrityConnections between TET proteins and aberrant DNA modification in cancerMyeloid malignancies: mutations, models and managementNew connections between splicing and human diseaseSplice isoforms as therapeutic targets for colorectal cancerMisregulation of pre-mRNA alternative splicing in cancerEmerging patterns of somatic mutations in cancerNew strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practiceAn extended U2AF(65)-RNA-binding domain recognizes the 3' splice site signalStructure, phosphorylation and U2AF65 binding of the N-terminal domain of splicing factor 1 during 3'-splice site recognitionCancer-relevant Splicing Factor CAPERα Engages the Essential Splicing Factor SF3b155 in a Specific Ternary ComplexU2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.SF3B1 mutations in chronic lymphocytic leukemia.Integrated molecular analysis of clear-cell renal cell carcinoma.Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.SF3B1 mutations constitute a novel therapeutic target in breast cancer.The neurogenetics of alternative splicingThe genetics of uveal melanoma: current insights
P2860
Q21090801-F1692B73-F36C-4B4E-A03E-4D76B329576CQ22242276-1E47DB35-56E5-4046-9096-75602D868CAEQ24309463-94FF532A-2C91-4C6A-A255-0F0ED9A9A8BAQ24314163-6065E3C7-99B8-4197-BAAA-C708AEE11C92Q24319165-B4D59438-6D42-4E41-B713-5F1734D68E25Q24596715-B42CDE62-C84C-4DEE-9FA1-B7FA4D2D3198Q24629306-9997501A-6427-4E43-97CA-1473A07ED8DBQ24632949-D3C2BBF9-B7D6-4655-AA28-6C5CDEF0D2D2Q26738664-9351A55E-B867-4477-BC49-78AEA36D956CQ26748543-08F34314-F138-42F0-8EB4-E83D847E04D5Q26752221-526AD203-792A-40BD-AF98-266514A35B06Q26768600-22C7D3F9-2F56-443B-A030-CD54F7585863Q26773907-2F290BF1-EC82-451D-96D1-AAFAB58EDD10Q26776393-E6F3BA59-AD10-492A-872D-2629D0484ADBQ26777822-CD3CF443-3D7B-4799-ABEB-138C2AD39CDBQ26779702-AA302355-8D2D-458E-8185-2CF52C073FB0Q26780366-EDCBF63D-B341-4DA2-B377-E951E609E09EQ26823040-0F3CC0D0-0590-4D8A-A43A-B1AF1C45B2BBQ26823138-A7A05F0C-D013-44E6-A9D8-2C7C1B36F638Q26827640-DE97D432-C211-43E5-883C-8BEE41047BBEQ26828777-AEC16FB1-BB4E-4077-9FAA-DFBD084D6DD8Q26852890-33D9CB7A-2FE8-49C8-9E7A-B7A035F0BCF2Q26858910-8968CC18-66CD-42AB-946B-AD461E220139Q26865671-0552E4F2-FD40-4FC5-AEA4-33F466C4E119Q27000577-7F9132F3-71C0-4021-A1D2-6ED7B7B8BE8CQ27005815-F24ADE27-BADC-4DE8-A324-41C858080774Q27006500-7657CDA9-530A-4B82-A3B4-27CEFB21AFADQ27007114-D4174913-67B4-4F93-B745-81BF63EF5C76Q27014126-B8E79F99-1F7D-4AA1-A4AC-66C5DB820177Q27016511-9C256D76-9C29-430A-9CD9-29B3A2226E9AQ27324522-66F8DC84-4377-4AD2-BD6C-C746067FF622Q27675199-904E7619-2512-4019-88EC-C66F7C487641Q27683637-022BAFD6-F858-4B7E-8A0A-4319FABC66D1Q27851921-A6A8F4DF-D794-42D2-8170-3B801F40F075Q27852162-576676E7-F0EE-450A-80E3-49C68A6F1479Q27852382-CC6C51D6-4EC1-43E4-A7D0-908371933CFEQ27852437-A89538CA-6F17-4A70-B73D-76F391306F1EQ27853097-FA4890D6-0905-4A4F-9ABA-EE4E94893AE1Q28069349-E0A60C29-7429-4DD0-A008-7446194FADDCQ28073150-59E75DC7-9C4F-47C8-B301-0FC5246EB9C4
P2860
Frequent pathway mutations of splicing machinery in myelodysplasia
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Frequent pathway mutations of splicing machinery in myelodysplasia
@ast
Frequent pathway mutations of splicing machinery in myelodysplasia
@en
type
label
Frequent pathway mutations of splicing machinery in myelodysplasia
@ast
Frequent pathway mutations of splicing machinery in myelodysplasia
@en
prefLabel
Frequent pathway mutations of splicing machinery in myelodysplasia
@ast
Frequent pathway mutations of splicing machinery in myelodysplasia
@en
P2093
P3181
P356
P1433
P1476
Frequent pathway mutations of splicing machinery in myelodysplasia
@en
P2093
Aiko Sato-Otsubo
Claudia Haferlach
Daniel Nowak
Florian Nolte
George Chalkidis
H Phillip Koeffler
Hiraku Mori
Hiromitsu Nakauchi
Ken Ishiyama
P2888
P3181
P356
10.1038/NATURE10496
P407
P577
2011-09-11T00:00:00Z
P5875
P6179
1008245757